Dong Liu is a Senior Partner at Boss & Young Patent and Trademark Law Office in Beijing, China, leading the firm’s Intellectual Property (IP) practice in medical device, bio-tech, clean-tech, and other emerging high-tech areas such as new media. He is also responsible for the firm’s IP licensing and transaction services.
Dr. Liu’s career stems from his dedication to the biomedical and pharmaceutical sectors working closely developing and implementing innovation process, invention harvesting, claim drafting, prosecution, litigation, and licensing in a global environment. Dr. Liu’s influence in the industry is brought forward from expertise focused on IP from North America, Europe, and China.
Dr. Liu’s past experience includes serving as a Senior Scientist and Group leader at a leader in preclinical neurobiology and provision of drug discovery and contract research services, based in New York. Dr. Liu initiated patent applications for innovations he had led to create, in particular, a repurposed compound for treating attention deficit hyperactivity disorder (ADHD) and a high-efficiency behavioral pharmacology assessment platform employing robotic automation, real-time video processing, and machine learning, both of which significantly contributed to the strong strategic IP assets that extended to support partners and clients. With the breath of expertise in the IP sector Dr. Liu was appointed In-House Patent Counsel and IP manager a Danish Foundation and Holding Company of publicly listed companies that command leading roles in the biotech industry. Dr. Liu led IP operations for the Asia-Pacific region within its Intellectual Property & Partnering Organization with a notable success at establishing the group’s first IP operation in China. Dr. Liu later joined a Fortune 100 company as the Intellectual Capital Manager and Director of Intellectual Capital Management and External Technology for Greater China. Dr. Liu once again was instrumental at successfully building China based local IP capacities that served the company’s Asia-Pacific business and operation in China, especially for the emerging markets of photovoltaic, flat panel display, water treatment, and pharmaceutical excipients.
A native of Shenyang, Liaoning province, Dr. Liu studied medicine at China Medical University and Neurology & Neurosurgery (PhD) at McGill University in Montreal, Canada. Over the years he has received a number of scholarship and fellowship awards as well as the first authorship of both Science and Nature publications.
His working languages are Chinese and English.